Product Detail

MEROZANĀ®

Meropenem IV (500mg & 1g)

Broad Antibiotic range against the majority of Gram+, Gramaerobic & anaerobic bacteria

  • Pneumonias and Nosocomial Pneumonias
  • Urinary Tract Infections
  • Intraabdominal Infections
  • Gynaecological Infections
  • Skin and Skin Structure Infections
  • Meningitis
  • Septicaemia
  • Polymicrobial infections


 

Empirical treatment for presumed infections in adult patients with febrile neutropenia

Monotherapy in patients with cystic fibrosis and chronic lower respiratory tractinfections.

Initial empirical treatment of nosocomial pneumonia and respirator pneumonia, for patients with delayed indications or prone to develop pluriresistant pathogenicbacteria.

For endoabdominal infections, the antibiotic treatment ought to fight mostcommon aerobic and anaerobic bacteria of the intestinal flora.

For patients with endoabdominal nosocomial infection or those who have recently been administered common antibiotics.

Meropenem penetrates the cerebrospinal fluid of patients with bacterial meningitis, accomplishing concentrations that are higher than those required for the inhibition of most bacteria.

Login Area